IL34 and infection: Blockade of CSF1/IL34 could increase the risk of infections due to a broad decrease in macrophage populations in multiple organs; however, we did not observe worse outcomes in a Listeria infection model compared to anti-TNF therapy, suggesting that risk of infection may also be reduced in clinical settings.